<SEC-DOCUMENT>0001159036-23-000020.txt : 20230316
<SEC-HEADER>0001159036-23-000020.hdr.sgml : 20230316
<ACCEPTANCE-DATETIME>20230315182828
ACCESSION NUMBER:		0001159036-23-000020
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230315
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230316
DATE AS OF CHANGE:		20230315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		23736575

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>halo-20230315.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:1dbd2b9f-f658-47b2-b098-9254a1e18aa5,g:b71a846c-c47b-4f61-8e84-59ed80a34a94,d:21267f2c61894a4a9aaea090c8fcfd4f--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20230315</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityCentralIndexKey" id="f-22">0001159036</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20230315.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i21267f2c61894a4a9aaea090c8fcfd4f_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">____________________________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of The Securities Exchange Act of 1934</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:59.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Report (Date of Earliest Event Reported):</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 15, 2023</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityRegistrantName" id="f-3">HALOZYME THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityFileNumber" id="f-4">001-32335</ix:nonNumeric> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityTaxIdentificationNumber" id="f-6">88-0488686</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityAddressAddressLine1" id="f-7">12390 El Camino Real</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityAddressPostalZipCode" id="f-8">92130</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityAddressCityOrTown" id="f-9">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:LocalPhoneNumber" id="f-12">794-8889</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:33.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.320%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:TradingSymbol" id="f-18">HALO</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( &#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (&#160;&#167;240.12b-2 of this chapter).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:right"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#231f20;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01 Regulation FD Disclosure.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, Halozyme Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release providing an update on a decision by the Opposition Division of the European Patent Office regarding one of the Janssen Biotech (&#8220;Janssen&#8221;) co-formulation patents for DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (daratumumab) subcutaneous (SC) formulation and reaffirming revenue guidance for 2023 and its total royalty revenue projections of approximately $1 billion by 2027, and thereafter to at least 2030. The Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">confirms that the license with Janssen is unique in that co-formulation patents covering DARZALEX SC with Halozyme&#8217;s ENHANZE&#174; drug delivery technology do not extend the time for royalty step-down beyond 2024 in Europe and 2027 in the United States.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This information is being furnished pursuant to Item 7.01 of this Report and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and will not be incorporated by reference into any registration statement filed by Halozyme, under the Securities Act of 1933, as amended, unless specifically identified as being incorporated therein by reference. This Report will not be deemed an admission as to the materiality of any information in this Report that is being disclosed pursuant to Regulation FD.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to press release attached hereto as Exhibit 99.1 for a discussion of certain forward-looking statements included therein and the risks and uncertainties related thereto.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991haloippressreleasefin.htm">99.1</a></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Press release dated March 15, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:20.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HALOZYME THERAPEUTICS, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 15, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">/s/ Nicole LaBrosse</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991haloippressreleasefin.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if4d1bb91c2c04802a4ee5481877e9acd_1"></div><div style="min-height:40.32pt;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:80px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Exhibit 99.1 </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:139%">HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">Company Anticipates No Impact on U.S. and European Royalty Revenues from DARZALEX FASPRO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%"> and SC through at least 2030</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">   </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:139%">Reiterates 2023 Revenue Guidance of $815 million to $845 million and Royalty Revenue of $445 million to $455 million   </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">SAN DIEGO, March 15, 2023</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> -- Halozyme Therapeutics, Inc. (NASDAQ&#58; HALO) (&#8220;Halozyme&#8221;) today provides an update on a decision by the Opposition Division of the European Patent Office (&#8220;EPO&#8221;) regarding one of the Janssen Biotech, Inc. (Janssen) co-formulation patents for DARZALEX</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> (daratumumab) SC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8220;We remain confident in our strong royalty revenue potential across our diverse partner pipeline. Today&#8217;s decision in Europe on a single co-formulation patent has no impact on our current full year 2023 revenue guidance. Janssen will continue to pay royalties to Halozyme on U.S. and European sales of DARZALEX FASPRO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and SC, in line with our total royalty revenue projection of approximately $1 billion by 2027, and thereafter to at least 2030. We also do not believe this decision will impact the ability of any other Halozyme licensee to obtain co-formulation patents for their innovations. Furthermore, today&#8217;s decision has no impact on the composition of matter patents in the U.S. and Europe for ENHANZE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">,&#8221; said Dr. Helen Torley, president and chief executive officer of Halozyme.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">&#8220;We are disappointed with the Opposition Division&#8217;s oral decision to revoke Janssen&#8217;s European Patent EP3370770B1.  We expect a written decision to be provided in the next several months. If an appeal is filed, it would suspend today&#8217;s decision and the patent would remain in force until the case is finally decided on any such appeal,&#8221; concluded Dr. Torley.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:124%">About Halozyme</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. As the innovators of the ENHANZE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> technology with the proprietary enzyme rHuPH20, Halozyme&#8217;s commercially-validated solution is used to facilitate the delivery of injected drugs and fluids in order to reduce the treatment burden to patients. Having touched more than 600,000 patient lives in post-marketing use in five commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> technology to leading pharmaceutical and biotechnology companies including Roche, </font></div><div style="height:27.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Takeda, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, Alexion, argenx, Horizon Therapeutics, ViiV Healthcare and Chugai Pharmaceutical.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Halozyme also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The Company has a commercial portfolio of proprietary products including XYOSTED</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">, TLANDO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and NOCDURNA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> and partnered commercial products and ongoing product development programs with several pharmaceutical companies including Teva Pharmaceutical, Covis Pharma, Pfizer and Idorsia Pharmaceuticals.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Halozyme is headquartered in San Diego, CA and has offices in Ewing, NJ and Minnetonka, MN. Minnetonka is also the site of its operations facility.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For more information visit www.halozyme.com and connect with us on LinkedIn and Twitter.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Safe Harbor Statement</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In addition to historical information, the statements set forth in this press release include forward-looking statements including, without limitation, statements concerning the Company&#8217;s expected future financial performance (including the Company's financial outlook for 2023) and expectations for future growth, profitability, total revenue, and royalty revenue. Forward-looking statements regarding the Company's</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">business may include potential growth and receipt of royalty payments driven by our partners' development and commercialization efforts and the potential impact of the decision on a co-formulation patent referenced in this press release on the Company&#8217;s 2023 financial guidance, ability of our licensees to obtain co-formulation patents and on certain composition of matter patents and the impact of appealing the decision. These forward-looking statements are typically, but not always, identified through use of the words &#34;believe,&#34; &#34;enable,&#34; &#34;may,&#34; &#34;will,&#34; &#34;could,&#34; &#34;intends,&#34; &#34;estimate,&#34; &#34;anticipate,&#34; &#34;plan,&#34; &#34;predict,&#34; &#34;probable,&#34; &#34;potential,&#34; &#34;possible,&#34; &#34;should,&#34; &#34;continue,&#34; and other words of similar meaning and involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Actual results could differ materially from the expectations contained in these forward-looking statements as a result of several factors, including unexpected levels of revenues, expenditures and costs, unexpected impact of the co-formulation patent decision referenced in this press release including unexpected results or delays in our licensees&#8217; ability to obtain co-formulation patents or in appealing the decision, the growth of the Company&#8217;s business, or in the development, regulatory review or commercialization of the Company&#8217;s partnered or proprietary products, regulatory approval requirements, unexpected adverse events or patient outcomes and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's most recently filed Annual Report on Form 10-K filed with the Securities and Exchange Commission.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:130%">Contacts&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">Tram Bui</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">VP, Investor Relations and Corporate Communications</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%">609-359-3016</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:130%;text-decoration:underline">tbui&#64;antarespharma.com</font></div><div><font><br></font></div><div style="height:27.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Dawn Schottlandt &#47; Claudia Styslinger</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Argot Partners</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">212-600-1902</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Halozyme&#64;argotpartners.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Media&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">David Rosen</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Argot Partners</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">david.rosen&#64;argotpartners.com</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">212-600-1902 </font></div><div><font><br></font></div><div style="height:27.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-13.5pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>halo-20230315.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1dbd2b9f-f658-47b2-b098-9254a1e18aa5,g:b71a846c-c47b-4f61-8e84-59ed80a34a94-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20230315" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20230315">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20230315_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20230315_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.halozyme.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20230315_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1dbd2b9f-f658-47b2-b098-9254a1e18aa5,g:b71a846c-c47b-4f61-8e84-59ed80a34a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_26538361-99d6-48c8-a558-fcd47b058309_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0e0b694f-5df3-4434-a946-4f61bf789463_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_53608d7c-36c3-43ff-b58f-185d1c5e13c4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d9f0e7a0-e657-4f18-9607-8ecc101a9b2e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e00945a9-9f64-4011-a74f-3e88a946aa45_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f4e866e9-54a9-4afe-b1e4-a55e1f9c0260_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ecb02cd9-a90d-457f-9811-031e9708a2c9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_59b4c89d-aef1-46c1-a8df-91ac047f09c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d26c5f50-0079-468d-a1a6-0c7895b10c29_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f8c25352-da11-46b1-83b5-9156ffd4b1b0_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2de9b193-559c-43af-b1d5-201606331051_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b782013b-30e5-4790-a20b-6e3dc190b0d2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d43467c8-16ba-4ee8-9953-957cb12ee4bb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_0e642e7e-0385-458a-a993-09e592add886_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_805ea944-8936-44a5-98e5-229d1d44d3e3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_34ccf086-28d8-4c6a-8aa6-d8909274f870_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_558be7b5-1569-457c-a3c4-0ec52a62c1ee_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a716ef15-82dc-47a8-80d3-3e27bdeac0d2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8c15a130-bce6-4fc6-a642-97beabc0c89e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2bf83908-4937-4846-b287-50c2321b1f56_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_085debc6-61e1-42cb-a0a6-0c1837cdfdf1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3cab9fc3-a8d7-497d-8f5b-0a2c970814de_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_5e45afad-2198-4c7b-9055-7a2c9575f08c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20230315_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1dbd2b9f-f658-47b2-b098-9254a1e18aa5,g:b71a846c-c47b-4f61-8e84-59ed80a34a94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.halozyme.com/role/CoverPage" xlink:type="simple" xlink:href="halo-20230315.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.halozyme.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d1e46f98-5970-48a1-ae46-d29c744b028c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_DocumentType_d1e46f98-5970-48a1-ae46-d29c744b028c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_54ce08c2-2275-48a2-ac6f-f8033bc9d140" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_DocumentPeriodEndDate_54ce08c2-2275-48a2-ac6f-f8033bc9d140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9a985db0-413d-41f2-859a-2fba448950f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityRegistrantName_9a985db0-413d-41f2-859a-2fba448950f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ae78ff48-6b85-4615-8935-c69642ad249d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityFileNumber_ae78ff48-6b85-4615-8935-c69642ad249d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_23258b16-4519-44d2-a39d-f5837d55a671" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityIncorporationStateCountryCode_23258b16-4519-44d2-a39d-f5837d55a671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1f9ce684-1d83-4c9f-84d8-baa7db41b7e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityTaxIdentificationNumber_1f9ce684-1d83-4c9f-84d8-baa7db41b7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_980ee864-6b75-4ad0-8dcd-784f0f4ae730" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityAddressAddressLine1_980ee864-6b75-4ad0-8dcd-784f0f4ae730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8cf97dc2-93c3-4044-a12c-b08fe4b2e820" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityAddressCityOrTown_8cf97dc2-93c3-4044-a12c-b08fe4b2e820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_087a74be-5350-4d6f-a4c2-5c151ac5f7fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityAddressStateOrProvince_087a74be-5350-4d6f-a4c2-5c151ac5f7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_33844c7e-98b5-4615-9d23-04fe7a715f11" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityAddressPostalZipCode_33844c7e-98b5-4615-9d23-04fe7a715f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_195df988-8921-4ff3-97bb-38ec8ec62c8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_CityAreaCode_195df988-8921-4ff3-97bb-38ec8ec62c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_96681d1c-55dd-46c5-a96f-06b0881ab64b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_LocalPhoneNumber_96681d1c-55dd-46c5-a96f-06b0881ab64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_f379e550-1a7a-4dfc-9001-842ba50441c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_WrittenCommunications_f379e550-1a7a-4dfc-9001-842ba50441c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_d26bd9d1-5088-4ab5-b638-1c64c0a6ac8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_SolicitingMaterial_d26bd9d1-5088-4ab5-b638-1c64c0a6ac8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_5d825026-f3fe-4c72-8e50-3e89bc2614d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_PreCommencementTenderOffer_5d825026-f3fe-4c72-8e50-3e89bc2614d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_d0284fb7-33fa-4d22-8505-292b95de11ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_d0284fb7-33fa-4d22-8505-292b95de11ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_48ad5ca1-42c7-4c5e-8976-9d593c083fd1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_Security12bTitle_48ad5ca1-42c7-4c5e-8976-9d593c083fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fc029aeb-4cdc-4085-9070-7db3357f4428" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_TradingSymbol_fc029aeb-4cdc-4085-9070-7db3357f4428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14cef825-2466-4483-9d52-c063f8099486" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_SecurityExchangeName_14cef825-2466-4483-9d52-c063f8099486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c882fa34-7315-4b25-9bea-4110ac341308" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityEmergingGrowthCompany_c882fa34-7315-4b25-9bea-4110ac341308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_69599a25-0e14-4077-917c-06a535d94beb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_AmendmentFlag_69599a25-0e14-4077-917c-06a535d94beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_8ba3b5fb-946c-4b6a-9ba9-69018c588196" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9892acbe-963c-4919-84b4-a07861114468" xlink:to="loc_dei_EntityCentralIndexKey_8ba3b5fb-946c-4b6a-9ba9-69018c588196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "W ;@# 2(  A$! Q$!_\0
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M9,%E2-<[L-(Z!O+<)N*D#&OB*.%I.I5DHQ75Z'+C,9A,OP\J^)FH06[;LO\
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MDI2,'!P7!P:_%'QYX\\8?$_QAJ'C_P ?:_<:IK&J7!FOKZY(W2-C    "J
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M"6L3C<WF*ZXF*^4!N(+LGEM^L%<-^T;\>_!_[-?PEU/XJ^,9$=;1/+T_3_M
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MW7[(_P +_$5Q#X7\,77E^+VMW54U;5$8'R6*DLT5LP V':#.'+*WE1./-?\
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M5O$>L6GA[0=-FO+Z^NH[>RL[>,O)/,[!415')9F(  ZDU^SG[)/[/FE_LR?
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M^.]G;W&DZ/JT=U-;K:NEO>:@J+]FM8^QBMXTB9@S,Q A5PXE9J2[@^Q],?\
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M^-/BBC,VH:EXF32I RC$<-M;QS+M/4%FNVSV.Q?2O8/^"J__ "8/X\_[A?\
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M[,&=63AT>8S2JQ).V11T  \[^"WPF\3_ !T^*>B?";P>B_;]:O!#')(?EAC
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M5[)\*?A3X!^"/@&P^&'PPT'^S-#TOS?L-C]JEF\KS)7E?YY69SEY'/+'&<#
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M"M>_:2U[3(Q?>-=0-EHDTBQ.RZ;:.R.R,,O'YESYJNC8S]DB;!&TGZN_;/\
MC>G[/O[-OB;XA6VI"VU3[";+0662,2&^G_=Q,BR<.8R3,5P<I"YQ@&NT^%?P
MZT#X0?#/P_\ "GPJ9FTWPWHMKIEBURRF5XH(EC5G*A07(7+$ 9))P*^$?^"T
M'QO.I^*?#?[/NCZ@K6^EP_VQK4<<D;C[3(&CMT; WQND7FMM) 9;I#@X4U^5
M\?\ $M3'5\7F;=G-VAY+X8KU44F_1L^CK4Z? /A\L/3?OPARIKK4GO)>DFY+
MLEU/ANOTK_X)'_LMR?#GX=3?M#>+K!H]8\66OE:-#*CHUMI@<-O(8 9G=%D!
MPP,:1,K?.PKXR_8B_9JO?VH/CUIG@NZM)O[ L6^W>)[J/@1VB'_59WJ0TK;8
M@5)9=Y<*0C5^QFGZ?8:1I\&DZ38PVMK:PK%;6UO&$CBC485%48"J   !P *_
M-.#LJ]K6>-J+2.D?7J_DM/7S1\;X6\-_6,1+-J\?=A>,+]9=9?\ ;J=D^[?6
M)-1117Z.?O 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 ?$'_  5&^!'[6/[5/Q,\)_##X4?#Z:3PAI2K+=:Q
M<7Z0VQOIWV-+*OF%FCAB"X98RX\V8 -G%?8/PP^'?AWX2?#K0_ACX2B==-T'
M2X;&S,H7S'6- N]RJJ"[8W,P RS$XYK>HH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .1_: ^(>H_"/X#^-OBMI%E#<W?AGPCJ6
MK6MO<$^7+);VLDRHV.=I* ''.*_+O_@@3^S?)XV^.VM_M*:Y82?8/!-B;+19
MF65%DU*[1D=D8?(_EVWFJZ$DC[5$V.AKZ[_X+<_$32O!'[ &O>'[]+K[1XLU
MO3=)TY[=1M25;A;UC(<@A#%9RKQDEF48P21Z#_P3:_9K3]EG]D#PK\/]0TUK
M?7-0MO[8\4++;F.0:A<JKO%(NYANA3RK?((#"W#8!)%?H66XW^Q> <3.+M4Q
M=3V:[\D(IR?I[SC\_N_+\VP'^L'B5A*<E>E@J?M7V]I.34%MO[BFM?L].ON%
M_?V.E6,VJ:I>PVUK;0M+<7%Q($CBC499V8\*H ))/  K\1_V@_BWJ/QW^-?B
M7XMZCYJ_VUJDDUK#-MWP6PPD$1V@ E(5C3/?;DY)S7Z9?\%1OC.WPF_91U31
MM.NVCU+Q?,NBVOEE"RPR M<L5;DH8$>(D E6F3IP:^1_^"5/[+<WQA^,B_&3
MQ-9-_P (]X)NHIX-Z2*MYJ7WX45A@'RB%F<;B0?)5E*R&OP'BB5;,LRHY;1]
M7V5^K_PJ[^9Y?B%+$Y_GN$R'"O7XI=DWLW_ABI/TE9:GV9_P3U_9=7]F7X#V
MUMK]@L?BCQ%LU#Q&S!=\+%?W5KD*#B)#RI+ 2/,5.&%>\445]IA<-2P>'C0I
MK2*LOZ[O=GZOEV P^5X&GA*"M""27^;\V]7YL****Z#M"BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140467363499440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HALOZYME THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0488686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12390 El Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">794-8889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HALO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>halo-20230315_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20230315.xsd" xlink:type="simple"/>
    <context id="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-22">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-2">2023-03-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-3">HALOZYME THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityFileNumber
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-4">001-32335</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-6">88-0488686</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-7">12390 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-8">92130</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-9">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:CityAreaCode
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-12">794-8889</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-17">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-18">HALO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315"
      id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MAMBT9];<F]BRO7]^WEW_):6_E>HUVS"FR7L2BVQ@;;1.KVT["S<LH=FE3)F
M.RNI$JIAJ-9VEBI&HR(HB6W/<;IV0KFPAOWBVDP-^S+7,1=LIDB6)PE5NQL6
MR^W <JV/"R]\O='F@CWLIW3-YDQ_3F<*1G:I$O&$B8Q+011;#:R1>WWCM4U
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MA H#E&^J%977DHHM)]W1ZTSO'R:/6D;KW$JY]_!*MAQSCG^T_ %02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ C9-O5@=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "-DV]6
M]MT0A^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "-DV]6F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (V3;U:1#'9G3@0
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M2P$"% ,4    " "-DV]6)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "-DV]699!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="halo-20230315.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.halozyme.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="halo-20230315.htm">halo-20230315.htm</File>
    <File>ex991haloippressreleasefin.htm</File>
    <File>halo-20230315.xsd</File>
    <File>halo-20230315_lab.xml</File>
    <File>halo-20230315_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "halo-20230315.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "halo-20230315.htm"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20230315_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20230315_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "halo-20230315.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20230315",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230315.htm",
      "contextRef": "i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.halozyme.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "halo-20230315.htm",
      "contextRef": "i996a49d17eaa4a3f8b5f04766abcec74_D20230315-20230315",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.halozyme.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001159036-23-000020-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-23-000020-xbrl.zip
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M?-EJ,+)J<9N!*. _IEK"#-*E20-11FM1:18I],8,;)\$&&.?(UCB*1DXT8S
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M'B55]05?X80QQSD%F:YLF'JZ%=IM@:*SIW..7)CDB5EX'2*0G"X@I4[9,Q_
MN>E+^W6AH5MFJ-74CJC4K6)(7<9\1;_&]VE\"+C2O&FP5W=K9=[.7I+RVW&Z
M[//[VX!R $+?F,\JY,U[L/Z@_$F(4,C,$C&7AY+QF==\I+%'US*CMEN9@3Q9
M<LNKZ8OG.1&3*9AYF;M:NFQ+Q44YJZB'NW[N^D:N%K'/"*([+*MH<:T:@>OL
MSJ%<]G9KBSTZVE?9E#/W=^5\C,)@>L5;?]94*_<^W[&OT)=(+O?N$AWSI\1
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M7+DSM+)9+E>?/#W86DQEZ8UJ>9.8JM+0J^7RL\=4IEYM;!J-K1EL3:\T\@6
MF\=42@U>P04_JADO[8&5"G1].X@@()/[3CT!+K<=)+Z()NW F??'N.R**\^"
MA5%PB^W<.^(J1'_,HW<T8FM=\ X'>8OR6!X1/4>,][U![)J.N^G>ARUA-F]R
M:X56HZ&5*HU&K;%DMVDQ@-MMK6YD+)<--KF GNP<N-J3JH>3_$ ,P?7]"7/[
MV.%R"0 #%CZKIK):-* ^_UM^WW\K.M9X?SJVL<"[^I7>TTEG%'K!!"0^KR+D
M/-#WEX'_"3L]2S=K9JO6UE=] ^JV(Q;NQ'$B%L?I?V<P ".S;O5"RS#+5HET
M/-(&VOR 7#'JO54O^0XU>+<P=!E B.7]SD,5?RD0-0HMRS3*I;?N'7>+U6WX
M>!%=!W?3,-8JM'I [BEG@^ ;-'2EP=TM:6SLN@"=!.&YU$'M,L6[A3\9\EU$
MES";XC)U+N=DRR@56FW@$53W.7T=G+ZUP&!C;*>RP9@[C$ L/*0>86-F)X+?
MXMHA1&@L_MXC[J?G_^S:5NO>"VHY.I:3B-%9%VY@RD&UL:BM^R^YR'D6 +PN
MAX&_L,AIF(56W:IHC4;#VJ&E?.OI.JM$>;^%\<\?&Z91/XR)8!X+D7+B2](/
M< ;M)0A>0D$TP.=9_[4&M-8.@?8\$.0D#($MJ&QO4%*?P,/!7%=MPT32X<%7
MJFPNR,@E*I/!(3&Z1.+16)!(;AB_W\V8E7DVK[_KJW9CALR^(6+(" TA^@ W
MB$M3_6!,^LP+[E!*6(BR) WM%^)R#]6*QZ!C@OD.2$\$(,!1X@GJLR")O0F)
MJ>"Q.Y%/I@\$?9 9S5:XL&!F6RZ!=@ 9_B0K<P,/.L?G,"+BN%D4-S=+^7D2
M:T^ ?(]\]3E:#/*EES=C:3EO7]#:_QIQ >S'O;3$3Y>1XH=!93\(O#X%7@J0
MZ-0CE#$(L.J5RN&J>'(;2%1QB?J;D@<LFZ6/A#,I4U>)QTC%K*;@$?-94I@<
MM6?42?O3%0'NZ5#Q40>P,F7L'>*G%X 1!U;Y@R^@[SCJO."I[#!XR#U99)32
M]1 T1H5"5#2#F[F4NBEJ*B5=U?P S@QP+B.&1@>/X\@\6W0!T87K8L"9#T#5
M'0:0^@LT:O8,D8^:(:/B:.9>?S\?IE3=#U2M1E4WCA,6;8"MV@YCBSP=5F6F
M5?;L?+!*ZSZ$U>K#5M/"UV;(C*-642"+((X,'R9$$T.J51H5 LV/!H&[<R;,
MJNFU<GV31)UR63<KSY]28QJ $NOY,W5,O6SF.\"V?)UIX0#O$VL^LCZ9BAD7
MX=:??WM8^.2ES6WFJESC(6E4%$;M(;%A+AWG6.+[;K@34;D:U)N,^H&WEVM)
M-Q=O(M7).V;=>9I%*W'%,O<#IOENR.&7>_N=@Z6OH>E+S[H>?B] ?\DIHW+:
M$\/L2V,S#;KJ*J<7(-$3@7US0/Z!AZ$-$M*(W%(OV21+\$.8+RO,U" J>SB5
M9$,=!-B*O-Z_)7T%W<RF!^ITQ^*<":WWPNZR!;X1(NMS&COT+Z6_Y N-;I@@
M9V?M#8#PHB;^VQK?;LT/TG9GP!^D?9"V4P/^(.T[(&VS6W.>M.#[K*MT7=_!
MM4E&^A-BRVUB&-8-S/N8/+6PL(?+8P)#9! H#'"F/8B".S'$)<X0]W5I3!SF
M0A?RV*7:NRM5LX6]A8T[=:M!F>P17#FM'\H-O*PVER<V0SRQB5D%V%1Z;8+9
MUTSU\6&SRVY-('OWB_[0"2ZB8A,/NM%G]P;R_\V3PB"#WN7B-<N&:[ZD>#LK
M1+5FI7S9F/+N,1C;WF-0Z9@9U3]+HMN*YIS;"V9IY?9"WMMDMI?HT777Z"=F
M3"U5=OX@5V,(JLP\9N/EHWX@%^N3F,E:(*DT(P0ON.1R 5]=08?\E7UY$^Q<
M7EJ*6/.!-BB)V"V/X3DP$-2W$4_4MO%D(E;&NR8=&CFQR@5Q5NT4E/?H=*=@
M5MWU=8C^EEVS?(B> N:M[%M\W&676S!K-M86"*M8.C82!DHMFA'S*.88/[@:
M\9Y:26;I_A':!Y(2L?J1IXQP]N]P*H60#IC6CQB]T:@+#32I=T<G<:'X4K<[
M/G;!WI:2^[J"C4A=+QGDB@T23Z6M?3HEISRVO2!.(J;GT>>%6^;^3&+!W<F6
M[/^%3^:O3SD@GZD7_#T9,;QB*J(A2\ PQ >DZ]LZV4,SBAFVX.]3+RF_&8?[
M$.K%"5AA"@89L^<!RXR""U#F62;=^B0)'7G&U8=J#K-E"A_Z%FSV(LQ #1Q5
MV7U3PYU$0<C@^4N*-P23"YF"C_X'/(#,(_195O?_@!LQ\\E//! ,"-M+AYO^
M/AVN'6CHWC,YAK+E6+JDTY.KWT_..K^]2'9 3:K\8Y)98A,0.UI97V*M\4)L
M;$#F%-3OO<HV $7VP"M3D8R2$>WODSCIVTF: DKV>NU],LMT<.$@1 K2C$8H
M1O#XS$\8&23<P:NDI33D'>58$Z]E$8$ +QP%$^J)R;0^8.Q/Y?#EJ0V9LSKF
MF.OE3<@_#-+GGI<B#5JK'\CF<+K"I$'#@($*@GC%*]%A7B&O5VNO"7W[U+Z!
M8"GQ'2WEK"O_';X6GR$&1JX!1X8P= 2^!RKA@\+),"K3 IBP)#[_"W@$$RQ9
M=07N[0! A3+(P$]Z;=549@^FB?6=\\\GY[]W%-:($R4#T&4/(!J!(H/*^<""
MP80X@8P$5?@G1RB  5*DF?QBP4+-">Y ,FP20"V03@5'JA1>B@D%I@;/,/K"
M %.>FHK?GK&]'LH$Z>D=[RB=/D.FNTGD\WBX$,3>.YQL\IG>JX9\B8<P$9$<
M[C/@/X3P,N>Z/[7/+O>8DYH[R77D(#0/EH5)-9G&R(TE,V[L8MGT^  G[70D
M(_J#Z64%=Q"HHZZC%N(H%!XIZ)UJ3;8/X(O3+K'U.WX__ON[#8"*/BIV>KDW
MYI,'<E*033;D\_)8G,R6DE3B(QE,#U:G_J8K"/,D)+Z'[BJ]  J,*IB,Z3W=
M#E95(IH;HK0=W)\;*AJ->Q'-4I=*!P!'G>R2(QIG?,I24F$:*HT7T#J'$7].
M])*-4]PX*O18P,U<>/+M:O)(++NCT=JG(+J#Z$ ["X(;F>21029>OP0#4UZH
MU#3K6YN37ZK 20(+Q3D?3U$AJ(V6 B&(NH'+6$/>YX)8EFY(3:<2&$F<Q5 V
MQ L4@.2F//%2GDS5*$[/1LU .W61).+QC3('B9^VDZ;H>?>J(()'8;:](RYK
MHGD+C>NGZ?K"/492^R?Y^KBG64Z;L>JPX]N9N>L5<[/K5M>U:M1@/-5G;[9N
MZ&8M7R+CYJ>7MWCCZ++T 34TF$FEUP(UI>]3<X',*IS/Z.:.'U7^9II/66Q'
M/,2?O^DH\X,E**/Z+;?L[,*Y^[527)?S[;I;$>41S<8R][(/IE!]N/4!$O6^
M&C:V+ -?6L-#Z:=3-^UR7Q\*8"WZY*,B75SR>OP>IMU71(A4YB(31\8#B[?Q
MSFCANS&[A991JJPT,&]3EFU< ""7%*9[78Q30-GPMHM3*JBZD75/S4F$FA2I
MJ(3(U\]AK(1[<C3;R<U<CU$REEP0DW/'>V6D^+&V_E)KZZ_S8H=\\7FO^_/Y
MR?77JTU?Q+.]/=795SBH;=*_$AZE\XI\20@'R_97G<2;$)LFL9QU\3B]%2%=
M]8E!8E 0J.NK^PQ\DILMK4NOE5; Z5J"BRJR.9J(81 !<4ZN=8)M7&W<L/2R
MN=&)*1,F/L;SO]C!-/5RJ?+LS=;TJK798-?W6*]M=KOSVM-=%;UN?F=SK9=[
MN\,'45LGZMONZWL+]#^O'F[OA23?(UZMMR>FM:\.>;>P_![!^6:%M57WL%/$
M/_/[Q[:*UC7K3Q^JN'MH_&GRE'? O3$]E"WFOWFV&!?).8?^&3FC/T5!'+-W
M["L_5/.]B2F'=N8ZM_V".UYOB)L?H-\&17A&_AU[I/6T?_B>#S7<#3')NV2^
M5SWL,9\'$?D/GG' +7:9CGI VD/.W)EL-74*(LJQP?I>]DV+_<"9P']#,?):
M_P]02P,$%     @ C9-O5HJKFV]N @  >P<  !$   !H86QO+3(P,C,P,S$U
M+GAS9,U56V^;,!1^SZ_P>)ZYA;2 FE1:JTJ3LHNZ5NW;9.! K(+-;-.D_?6S
M'5!*VFR-M(?Q@CGG^\[]F+/S35.C1Q"2<C9W M=W$+"<%Y15<^?VY@K'SOEB
M,CG[@/']I^LENN1YUP!3Z$( 45"@-54K=%> ?$"EX VZX^*!/A*,%Y9TP=LG
M0:N50J$?3O>U(@V*K BSI,3ER2S&T6D6XLQ/8IR$LX@$$,2$S#Y6:78:D#@Z
MR7&N(3@J3P(<0QSA60)%[)-I1)+(&MW(5.8K: C2B3&9;N3<62G5IIZW7J_=
M]=3EHO)"WP^\^R_+'Q;J]-B:LH<1>I.)>L!//:/.B(0!OB(U'\&-X/FI 3?G
MC6?2]:?!S$%$*4&S3L$5%\TEE*2KU=SIV*^.U+2D4.B2UV"*.@*\4"LB*E!?
M20.R)3F\P^EB@I"I!6U:+A1B;U+[8@1)DG@;DYV#MK5;\IPH.Q 'BV'QV!QQ
M$.)IX&YDX7CO<CLV1)E4A.5PC&_]A0?>OXAAU]GC8AAXQ\=@C4G(W8H_>@50
MT[GP;??R$-P<L#F,?1+&N+)\(^EE;4M9R;<"+3*!IT/TUU .R_)J ]X8$?M*
MB<@%K_\R3UXK> M"49 OM\<:6 DH-5M/+QZF]F=-,E=',D!>.1BWP*@]38%Z
MN<MDX*JG5G.E;D -V]K\SXFW HY-7%.DOC)LHX_,W_!OM![18NY<<'W[?R>5
MCL_(;Z\_'[Y>K.,=8; ZV"V@I(S:R?/M$R"\^V%@9)G(4,^\?<*>J4Y"\8TM
M['D_TY[<0_Y S$F==_7QO%U8!VF]<*ADOVG>>-6VWR_6T0JV.[Z8_ 902P,$
M%     @ C9-O5FIE<21F"@  25X  !4   !H86QO+3(P,C,P,S$U7VQA8BYX
M;6S57%UOVS@6?>^OT&9?=H&R)B52(HLV@VZF'12;:8LF10>[6!C\4B*,+06R
MTB3_?BG93BR;MD4J5CTOK6)?79Y[I'-Y?4GIS2_WTTGP0Y>SK,C?GJ!7\"30
MN2Q4EE^]/?EV^0'0DU].7[QX\S< _OC7U_/@UT+>3G5>!6>EYI56P5U670??
ME9[]&:1E,0V^%^6?V0\.P&ESTEEQ\U!F5]=5$,(P6O^V?(V44*%@*4AC0@%.
M1 @$9!2PD&".-**<DY=7KT6".,6Q!-*8 )S&"%!-,2!,*PIYA#G#C=-)EO_Y
MNOY'\)D.3'#YK/GS[<EU5=V\'HWN[NY>W8MR\JHHKT8AA-%H:7VR,+_?L+^+
M&FO$&!LUWSZ:SC*;H7&+1G_\?GXAK_64@RR?53R7]0"S[/6L^?"\D+QJ.-^+
M*]AJ4?\%EF:@_@B@$$3HU?U,G9R^"((Y'64QT5]U&M3_?_OZ<>N0;%1;C')]
M55_9+[K,"G51\;(ZYT)/#/K&6_5PH]^>S++IS40O/[LN=6IW.RG+EM<:):M1
MHKA&^?=M@XUZP'\FO-4FUF< UX3[Z;DP[N+TT[/!O33Y01\>\,HPO2'/;ZCW
MN1KJWGT<JC?TPR-^KMNBJ/AD@-OB:9@5R)/Z@W-SM!BF=K0CF3;C+%+W"E1]
M7^E<Z7FV;+D.,O7VQ!R-E<[&[_,JJQ[.S+Q7\LE'<\+]O_7#.(Q)1",S%3&F
M8H"II( 3,XNE4IE9"A(:03:N'F_JL<[!MXOE^,T@>T8X<8BMVJ+14L^*VU(^
MS6[3B6W*,K-5/;_14<ZG>G;#%R<8F'4A,$=^.@<9+% &#<S X'PS>@K)A\C)
MX>F9'!DSA6QAF=3E0%&N1U_(_=$_Z6MF@#>AS[1\=57\&)ES#05A6!^ ^J"1
MU7:/HXV+]ZY<XN2EW,/SPF(D"U/KW%2@17E=&W8,J"HZ7O<Y=6;8DZ HE2Y-
M_6H)P7+_7?+[C\KXS-)L7H5]NIT*78ZAAB)F. 5$I1' .,+ U)5Q4V^*-*'F
M.'(3]):1CE38!FW0AAO,\;H*?!O!787^#+0-(WAWQCR$OX>-'@E@F^>!$\&>
M #<3PKX3?!/#.Z7,33);_&>J"XW&)(HA58D$42Q-4HC2% A"4X H44@2C2*)
MW9*"990C30@+B"^7!T$--OB<:]>$8".V:S+H2=<PB<"=*8]$L(.)'DG YG7@
M!+ CL$WQ[S)V%_YER>MFU\7#5!23L6(IU F'0,<D,?,^HH#%, %42XD@XDR$
MNJO86YZ/3> +<,$<77<YM^G:+V%O$@XLVX[Q.XG4&JN7,-N>!A.C-8!5 =H-
M?&?;#]E$+PI#;7[Y8\(98&F, 88( 9Z80CS2E-8E..>8N$VR3\Z/37J+&:,&
MZ%E>KQ#7=1+UHV.8N;,+$QZSY6;(/2;)%6<#SXV;86Q.B18;=U%^*?59,9UJ
M@ZM>X?DXF]WJ\K)NCY6?T]3<:RG6-(XU P0;I6*>:B"0QG732Z.421C&L*M(
M]PUV;*(U>(%< 1S,$0=SR$&#N;N,]U*]7];/2>"!9=Z+.R?A=R7%*Q'L=3Y8
M8N@:YFJBZ'R.>^*X*":9S"I3&/S.C18S;NY<*6 H%0.<004P25+ J)G4880T
M2R#EH>S<&M]T?VS)X0EAL(38/1=8V-NO_GZ<'%CO+G0XR7M[U%Z"MK@;3,+;
M0UD5[0ZKGBVN,W/XN;PL[O(Q80)+RA3@.D4 Q]+4WE09P2(N(4Y2R&3BU>!Z
M&N/8!+O>M*F1&AZ#&JMG:VN%4,?&EA]- [>U.C'DW]+:Y*!_0VO%Y\]I9VT&
MM;6993'U%?C'7!;E35$V??&+RN2-L^(VK\J'LT+IL0IC25(" 82)J>%C:F2/
M> R@3"@C D$9.JY9[QSO2(7?POPR:%#7=_<">5!#=\T#NWGOFA.>C<UA\D,O
M(CW212=Z>J2.W?X'3B.=@MU,*=U.<T\O]9;%R9?K(E_VGE(J0Q*1$"B.ZL)!
M($ C04SA0.(T55@@T;D?L.[\V!)'@R]H #HW[3:(VY\,^M!Q8.4[,.$D\&TA
M>ZEYP]E@TMT6QJI.M]KT+.J_%+.*3_Z3W3133J@T$XA%@! F 8YX"@12Q!"%
M8AA'$8($>=7UK6&.3:CKA>L<;&#0>LWJ5F8="WQOO@:N\;M2Y5_F6YGH7^FW
MW?Z<8M\:VM9ZWV[M+O_O9595.J\[>[?Y8B_,;"P2:D0>"1!!30!.& 0\A +$
M.E(2,2B@"KLJWSK"L8E^ 3)HH^RN=3N-^V7>FYP#*]R1%R=A[XS=2]-VCX/)
M>6= JTK>;>@NXOK'_[M2\_D/=!SA.)$4H%AP@+6F@#$2 482*5"H-1:BJW97
M'1^;9)N&4@W.<5IND;5?H;X4'%B8':-W$J0M5"\=MAP-)C\;_%756;_W$%OQ
M0Y?OQ*PJN:S&4,<XU(D&,*)FIB24 \Y,R0R9)BSD2E$:=U;;JN>CDUL-+OCO
M$M[_' 37(JR#XGQI.+3DNC+@)CI;M'ZJ:WD:3G:V %JZLQIXK!)K>6LFS@<4
MBLNLFN@QA41SAC&@+(H!QIP 1DV]&H9,(86QBG3GIRW6G1^;_!I009$&*/R'
M^&>PA.NP2KS.WGXA]N'DP%ITI<-ME7A+W'YKQ.O.AELAWA)&:WUXFXV[/)</
M]E^:4\<1EC*%- 8A511@&7- .8^!H@RR,,$I33IW=E<='YLL']]F4(/K+L86
M5_N%Z,O @478+7@GZ=DB]9)=R]%@DK/!7Y6;]7MWJ;TS/E3MY\.$7XT)H4(G
M@@!$8E9OE9* 1Q(#J"4)>1Q*I#L_<M#R?&QB>P07U.BZJZU-UWZY>9-P8+UU
MC-])<-98O137]C28Y*P!K&K.;N!??KZ_E]?FJNA/YDJ->8)BG2(":*@DP FG
M@$(5@4B'B5":2X=&J6V 8Y/@$F.P!!G4*-VKT!:)W2M17VH.+$Q'5KR*45OH
MO0K2EL/!BU);.+;"U&KGN\KY55]E]<_0O&KN.RH1X2B"0$A=/Z,O8\!C' *6
M",V%A)*RSA.G;8!C$^]BN>X)I*-XK23N%V]?:@XL7D=6/-8N[:'W6+5<<SCP
M>J4]G,V5RBUVON)]/]7E599?_586=]7U63&]X?G#.!0IC1@TOS%9E !,<0Q$
M2!- H RC$ F4DL[]UQWC'*F4EUB#.=A@@=95TG9JNRJ[-V'#"-R5*P^A[V2B
MA][M?@>6_<[@-M6_V[SG/J5F4^+G\DM9_,@,_#&D1&EAYN\8:01P* 7@L-F4
MC&B42)6JU&^GTMI 1YH&'C?@/&Z?70+VW*VTSF_75-"?M6%R@0=A_GN6MK#1
M?]?2NN.?LV]I2WA;=RYML_?O.#^^/_%7XWD<22Y8*J/Z&213$;!$ 9H2 6#]
MR& "*<*J<U5O'>'8DL!C&W:.,C P@QJG>SNZ363WOK0W/4,UJ+LRX]6KMD;?
MJVG=]CAX]]H:D*V-;3?L_>* U>?8B<:$IUR!$+%Z(2D1@$%"0%*KF20DA51Z
MOC+@K_2R@&=Y2T"O]P/\1=X,</!7 ASH90#'\!H MQ< N#SZOWHESLW1Z8OE
M)]G\W>.G+_X/4$L#!!0    ( (V3;U;;._>9J@8  .@P   5    :&%L;RTR
M,#(S,#,Q-5]P<F4N>&ULU9I;;]O&$L??_2E4G=>NM7?N&HD+UTT*HVYC)"Y2
MG!=AKQ(1BA26=&R=3W^&M-WXVA*B #& (4O4DC/[GY]F9X=\\]/-JIA\#:G.
MJ_+ME!SBZ224KO)YN7@[_?/R/5+3GXX/#M[\@-!?/W\\G_Q2N:M5*)O):0JF
M"7YRG3?+R6<?ZB^3F*K5Y'.5ON1?#4+'W4FGU7J3\L6RF5!,V=-OTQ'QUE.K
M(XI2*,0S2Y'%6B%-!3<D$&6,^'%Q9#-B%)<..1B">)0$J: X$CIXA0WC1O/N
MHD5>?CEJ7ZRIPP0F5];=Q[?39=.LCV:SZ^OKPQN;BL,J+6848S:['SV]&W[S
M;/PUZT83K?6L^_;OH77^TD"X+)G]]?OY)[<,*X/RLFY,Z5H#=7Y4=P?/*V>:
M3O-_]6ORZHCV$[H?AMI#B%#$R.%-[:?'!Y/)K1RI*L+'$"?M_S\_GCTRN31%
M];_-*ARZ:C5K!\Q.*\#APBQ:=[O3F\TZO)W6^6I=_'ULF4*$Z\#)J(TK9D2T
M1O_S[>39-_OK%&I IIOO.1RXNT9K;3M?PDT32A]NYWAOI:C<HT%%JW"5[L\L
MC U%=W3N0S[OKGQBZR89U\RUTM0X&Y"6S"&NB4:*6XX,SI0DA' NU9.I@]LU
M^-T%I [N<%%]G<&%(3"4MF]:76BGR3-SM]ILY_?][^\2QLX]"5Q&^+4(G6'$
ME2'(P!'DJ789YQ93Y0:Y_=#:8Z\?QO0DN4F5?$B00.[-F>2>Q?<QO'<C9FN3
MX$+(+?/"WY_=9I)=Q*JI=J#<;5C W>D$9AU#2L&?WT;EU<EU,VL@K89NY"XB
M?A%27OEWI?\%\NY<<!>P<A11FHEV A09)R&-*LR8==H3CG<2^D=F>S% Q\_
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MW1?M2_MH_/'!_P%02P$"% ,4    " "-DV]6I[U":*T-  ",/   '@
M        @ $     97@Y.3%H86QO:7!P<F5S<W)E;&5A<V5F:6XN:'1M4$L!
M A0#%     @ C9-O5LR6;2\5$@  %(T  !$              ( !Z0T  &AA
M;&\M,C R,S S,34N:'1M4$L! A0#%     @ C9-O5HJKFV]N @  >P<  !$
M             ( !+2   &AA;&\M,C R,S S,34N>'-D4$L! A0#%     @
MC9-O5FIE<21F"@  25X  !4              ( !RB(  &AA;&\M,C R,S S
M,35?;&%B+GAM;%!+ 0(4 Q0    ( (V3;U;;._>9J@8  .@P   5
M      "  6,M  !H86QO+3(P,C,P,S$U7W!R92YX;6Q02P4&      4 !0!0
) 0  0#0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
